COMMUNIQUÉS West-GlobeNewswire

PotNetwork Holding, Inc Creates New Market Opportunity for Domestic and International Pet Retailers with the Launch of Diamond CBD’s “MediPets” Product Line
26/03/2018
FT LAUDERDALE, Fla., March 26, 2018 (GLOBE NEWSWIRE) -- VIA OTC PR Wire -- PotNetwork Holding, Inc (OTC Pink:POTN) On Friday, March 23rd, PotNetwork Holding Inc.’s wholly owned subsidiary, Diamond CBD Inc., closed out a [...]
Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results
26/03/2018
NESS ZIONA, Israel, March 26, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL ) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018
26/03/2018
Geneva, Switzerland and Boston, MA - March 26, 2018 - ObsEva SA (NASDAQ: OBSV ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Athenex, Inc. Announces Fourth Quarter and Full-Year 2017 Results
26/03/2018
Fourth Quarter 2017 and Recent Business Highlights: Met enrollment targets and received positive feedback from the US FDA for Oraxol Phase III Clinical Trial in metastatic breast cancer Announced strategic partnership [...]
Akcea Convenes First FCS Global Connection Summit
26/03/2018
CAMBRIDGE, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat people with serious [...]
Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
26/03/2018
THOROFARE, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, has entered into a three- [...]
Apricus Biosciences Announces Scheduling of Vitaros™ End-of-Review Meeting with FDA
26/03/2018
SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that its end-of-review [...]
Axsome Therapeutics to Present at H.C. Wainwright Annual Global Life Sciences Conference
26/03/2018
NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders [...]
Zynerba Pharmaceuticals Announces Publication of Preclinical Data in Neuropsychopharmacology Demonstrating Effect of Cannabidiol Gel Treatment in Reduction of Relapse in an Addiction Model
26/03/2018
DEVON, Pa., March 26, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]
Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults With Type 1 Diabetes
26/03/2018
New Drug Application Submitted to U.S. Food and Drug Administration Marketing Authorization Application Submitted to European Medicines Agency THE WOODLANDS, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Lexicon [...]
Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem's Strategic Advisory Board
26/03/2018
HAIFA, Israel, March 26, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI ) (TASE: PSTI ), a leading developer of placenta-based cell therapy products, announced today that Dr. Roger Jeffs has joined [...]
Loxo Oncology Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancer
26/03/2018
STAMFORD, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers [...]
Avivagen Announces Continued Growth and Adoption in the Commercial Use of OxC-beta™ Livestock in the Philippines
26/03/2018
OTTAWA, March 26, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]
Fennec Provides Business Update and Announces Fiscal Year Ended December 31, 2017 Financial Results
26/03/2018
Phase 3 SIOPEL 6 study met primary endpoint (p=0.0033) NASDAQ listing in September 2017 Two equity financings completed Strong financial position at year end with $28.3 million in cash and no debt RESEARCH TRIANGLE PARK [...]
Peeps Marshmallow Candies May be Among Worst Dental Offenders Says Doug Disraeli D.D.S.
26/03/2018
SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- While peeps may be delicious in springtime, Dr. Doug Disraeli warns that the marshmallow bunnies and chicks are at the top of his list of candies to avoid. Says Dr. Disraeli [...]
Amphastar Pharmaceuticals to Present at the Needham’s 17th Annual Healthcare Conference
26/03/2018
RANCHO CUCAMONGA, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced today that Bill Peters, CFO will be presenting at the Needham‘s 17 th Annual Healthcare Conference [...]
Helsinn Advanced Synthesis wins across all categories at the 2018 CMO Leadership Awards
26/03/2018
H elsinn Advanced Synthesis wins across all categories at the 2018 CMO Leadership Awards For the fourth year running, Helsinn Advanced Synthesis has won first place in all core award categories at the 2018 CMO [...]
Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018
26/03/2018
Curetis To Attend Key Investor and Scientific Conferences In The Second Quarter 2018 Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen, Germany, March 26, 2018, 02:00 a.m. EST -- Curetis N.V. (the " [...]
Notice of Annual General Meeting in Immunicum AB (publ)
26/03/2018
Press Release 26 March 2018 Notice of Annual General Meeting in Immunicum AB (publ) The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, are hereby invited to the Annual General Meeting on [...]

Pages